Rutan G H, McDonald R H, Kuller L H
Department of Veteran Affairs, University of Tennessee, Memphis 38104.
Am J Hypertens. 1992 Dec;5(12 Pt 1):880-6. doi: 10.1093/ajh/5.12.880.
We compared the blood pressure (BP) measurements obtained with a random-zero sphygmomanometer and an ambulatory BP monitor in older persons with isolated systolic hypertension at one site of the multicenter, randomized, double-blind clinical trial, the Systolic Hypertension in the Elderly Program (SHEP) randomized clinical trial. The subjects were community-dwelling elderly participants with isolated systolic hypertension enrolled in the SHEP study and already receiving stable doses of double-blind medication (n = 35 for active treatment group; n = 32 for placebo group). We measured seated (clinic) BP obtained with a random-zero sphygmomamanometer, pulse rate, and BP and heart rate measurements obtained with an ambulatory BP monitor (average 24 h, daytime, and nighttime BP and heart rate). Across treatment groups clinic and ambulatory systolic BPs were not significantly different, but the placebo group had higher ambulatory, but not clinic, diastolic BPs. Within each treatment group (active treatment and placebo) there were no significant differences between clinic and average 24 h, daytime, or nighttime ambulatory systolic BPs. There were also no significant differences between clinic diastolic BP and average 24 h, daytime, or nighttime ambulatory diastolic BPs in the active treatment group, but in the placebo group average 24 h diastolic BP obtained by the ambulatory monitor was 4.6 mm Hg higher than clinic diastolic BP (P = .001). The average 24 h heart rate was 6 to 7 beats/min higher as measured by the ambulatory monitor compared to clinic pulse (P < .01). In the placebo group of this study, average 24 h ambulatory diastolic BPs were consistently higher than clinic diastolic BPs.(ABSTRACT TRUNCATED AT 250 WORDS)
在多中心、随机、双盲临床试验“老年收缩期高血压计划(SHEP)”的一个试验点,我们比较了在单纯收缩期高血压老年人中使用随机零点血压计和动态血压监测仪所测得的血压值。受试者为参与SHEP研究且已接受稳定剂量双盲药物治疗的社区居住老年单纯收缩期高血压患者(活性治疗组n = 35;安慰剂组n = 32)。我们测量了使用随机零点血压计测得的坐位(诊室)血压、脉搏率,以及使用动态血压监测仪测得的血压和心率(24小时平均值、日间和夜间血压及心率)。各治疗组间诊室和动态收缩压无显著差异,但安慰剂组的动态舒张压较高,而诊室舒张压无差异。在每个治疗组(活性治疗组和安慰剂组)内,诊室血压与24小时平均值、日间或夜间动态收缩压之间无显著差异。活性治疗组的诊室舒张压与24小时平均值、日间或夜间动态舒张压之间也无显著差异,但在安慰剂组中,动态监测仪测得的24小时平均舒张压比诊室舒张压高4.6 mmHg(P = .001)。与诊室脉搏相比,动态监测仪测得的24小时平均心率高6至7次/分钟(P < .01)。在本研究的安慰剂组中,24小时平均动态舒张压始终高于诊室舒张压。(摘要截断于250字)